NovaSterilis

02/02/2026

With advanced modalities like , manufacturers can bring sterilization in-house to reduce turnaround times from 2 weeks down to a few hours.

This means no longer slows down your workflow or supply chain.

NovaSterilis supports this shift by helping manufacturers integrate scCO2 efficiently.

01/28/2026

Radiation and antibiotic washes force trade-offs between and graft performance.

However, clinicians desire terminal without compromising tissue structure or bioactivity.

Dive into how sterilization meets this demand:

Learn how supercritical CO₂ sterilization delivers terminal sterility while preserving tissue graft integrity to meet clinician demands.

01/26/2026

Irradiation can compromise structural and biochemical properties of amniotic membrane allografts.

sterilization is shown to preserve growth factors at levels exceeding gamma and e-beam processed tissues. Read more: https://bit.ly/41nAd9L

01/22/2026

Post-processing choices can influence mechanical performance of additively manufactured bioresorbable scaffolds.

Heat treatment and introduce measurable process–structure–property–performance relationships across resorbable polymers.

This study evaluates these effects on AM scaffolds using . Read more: https://bit.ly/3YwAzKa

01/21/2026

There are a few common misconceptions regarding the feasibility and cost-effectiveness of in-house .

The reality is: alternative sterilization modalities (like scCO2) can easily be implemented into existing manufacturing settings while significantly improving turnaround times.

Dive into the cost, feasibility, and capability differences enabled by :

Explore the role of in-lab sterilization equipment in life sciences R&D and its impact on research quality, safety, and efficiency.

01/20/2026

The brings access to controlled supercritical CO2 processing for laboratory research.

Configurable vessels, pressure ratings, and controls support method development and material evaluation.

This platform brings capabilities into everyday lab workflows. Compare the different models: https://bit.ly/3LCCauw

01/16/2026

Liquid and submerged remain a challenge to terminally sterilize without compromising structure or activity.

This white paper details a low-temperature, tunable process validated for ECMs, hydrogels, scaffolds, and bioactives.

Learn more about the of temperature-sensitive materials using : https://bit.ly/3QocTU2

01/14/2026

is often treated as a black box with limited process visibility.

With our NovaGenesis VP-1000 equipment, you can visualize material response in real time.

Discover how observation can lead to safer design and optimization using : https://bit.ly/3KkJnz8

01/12/2026

Sterilization plays a major role in the quality and mechanical performance of allografts.

Legacy modalities can risk collagen disruption, mechanical degradation, and reduced biological performance.

Explore innovative tissue sterilization strategies using : https://bit.ly/4k5NF9B

01/09/2026

This video demonstrates real-time material response during exposure.

Annotated footage highlights foam color shift and structural change under controlled conditions.

It provides direct visual insight into parameter-driven material behavior using scCO2.

Dive deeper with additional videos using the VP-1000 system: https://bit.ly/4qZsI4H

01/08/2026

Radiation and antibiotic washes impose trade-offs between sterility and tissue performance.

Clinicians increasingly require terminal without compromising graft integrity.

Explore how addresses these longstanding limitations in tissue bank sterilization:

Learn how supercritical CO₂ sterilization delivers terminal sterility while preserving tissue graft integrity to meet clinician demands.

01/07/2026

This white paper analyzes preservation during processing for amnion tissue sterilization.

Data supports compatibility while maintaining native biological signaling.

Download the white paper to review the methods and findings: https://bit.ly/3F2T2aJ